DKK1 and hepatocellular carcinoma: Similarly, our data showed that when DKK1 was inhibited by the small molecule, WAY-262611, the anti-tumor efficacy of SOR on cell viability, invasion, migration, and colony formation was significantly enhanced in HCC cells.